Institute for Regeneration
Medicine at UCSF | 
situation:
Stem cell therapy offers the promise of medical
treatments for an enormous range of conditions. However,
the practice can represent a social and ethical
challenge.
Initially created as
the governing body for all stem cell research facilities
at UCSF, the Institute for Regeneration Medicine expanded
to align and coordinate over sixty independent research
initiatives, implementing improved methods of collaboration,
communication and efficiency.
By 2004 (and only two
years old), the IRM was established
as a pioneer in the field of stem-cell research. Encompassing
work on multiple cell types as well as cardiovascular,
neurological and cancer research. The IRM was
able to embrace and expand upon UCSF’s traditions
of academic excellence, collaboration and progress.
The IRM was
making strides in all key areas of regenerative medicine
research and was granted four of the twenty-two derivations
of stem cells eligible for federal funding, as well as
attracting initial funding from private sources.
challenge:
Recognized as a premier facility in stem
cell research among the scientific community, the IRM had
to introduce a strong leadership brand to attract, interest
and funding from foundations, institutions, private donors
and the general public alike.
|

solution:
Through strategic branding
practices, jungle [8] positioned the institute
as the industry leader, while supporting their commitments
to innovation, efficiency and compassion; creating and
solidifying their new market position.
jungle [8] worked
with the IRM to first establish
greater awareness and recognition of the institute, visually
translating these core values into a reflective identity.
The jungle [8] team leveraged public interest
to create a memorable leadership brand, focusing on the
human element of research and inviting the public to
engage in a relationship with the brand, barriers many
other research institutions avoid.
Today, the institute
continues to prosper attracting funding and support from
both the public and private sector. During the first
quarter of 2007, the IRM was able to
fund their research grants, for the first time. |